PATENT CLAIM ANALYSIS

Application Number: 15763047
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "133100"]

Abstract:
The present invention provides methods and compositions for treating atherosclerosis in a subject comprising the use of therapeutic compounds to reduce Reelin in the circulation of the subject, thereby reducing the adhesion of leukocytes to the vascular wall. The invention also provides methods and compositions for reducing leukocyte adhesion to the vascular wall in a subject.

Claim (Index 15):
The method of  claim 10 , wherein said therapeutic compound performs a function comprising:\n (a) reducing or inhibiting the expression of a gene encoding Reelin; (b) reducing or inhibiting the expression of a Reelin protein; (c) reducing or inhibiting expression of a receptor for Reelin; (d) reducing or inhibiting the function of a Reelin protein; or (e) binding to Reelin protein in such a way that the function is reduced or eliminated.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 90.0
- Lexical Diversity: 1.78788
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14969959', '13206174', '12595122', '14746281', '12300148']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6592933514949412
- 35 USC 102 Novelty (BERT): 0.5232628594244192
- Combined Prediction Score: 0.645690302287889
- Mean Citation Score: 256.919302
- Max Citation Score: 274.11285
- Similarity Product: 161.76720790954823

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test